Researchers have revealed the top 10 drugs by annual revenue in 2025. Here, we investigate the indications that necessitate these treatments and the delivery systems they employ.

This webinar provides an overview of the important UV/Vis spectroscopy-relevant changes in both USP and Ph. Eur., taking a closer look at their impact and the solutions available to ensure compliance.

A Phase II trial for an inhaled cystic fibrosis drug, intended for adults and adolescents, has enrolled its first patient.

A new report has said the osteoarthritis therapeutics market is estimated to grow due to rapid increase in the geriatric and obese population.

A new report has shown that from 2016/17 to 2018/19 clinical research has generated an estimated £8 billion of GVA for the UK.